A detailed history of Geode Capital Management, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 35,716 shares of DRTS stock, worth $111,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,716
Previous 35,716 -0.0%
Holding current value
$111,076
Previous $90,000 5.56%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$2.98 - $4.24 $7,867 - $11,193
2,640 Added 7.98%
35,716 $135,000
Q2 2023

Aug 11, 2023

BUY
$2.76 - $4.72 $17,857 - $30,538
6,470 Added 24.32%
33,076 $144,000
Q1 2023

May 15, 2023

BUY
$2.78 - $4.83 $17,691 - $30,738
6,364 Added 31.44%
26,606 $76,000
Q2 2022

Aug 12, 2022

BUY
$5.19 - $12.67 $105,055 - $256,466
20,242 New
20,242 $182,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $215M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.